Commercialization at SRI

As one of Canada’s Top 10 research hospitals, Sunnybrook Research Institute (SRI) is at the forefront of healthcare innovation and commercialization, transforming research into real-world impact. With over 1.3 million patients cared for annually, SRI’s world-class scientists, trainees, and staff are driving breakthroughs through 650+ life-changing clinical trials and pioneering advances in medical technology, imaging, and therapeutics.


SRI fosters discovery within its 250,000 sq. ft. of state-of-the-art research space, including advanced preclinical facilities, a medical device development lab, and Toronto’s first 7-Tesla MRI. As home to Canada’s only Centre for Research in Image-Guided Therapeutics and the national INOVAIT network, SRI is accelerating innovation with over $39 million in non-dilutive funding for medtech projects across the country.

With a proven track record of 1,000+ industry agreements and partnerships with 500+ companies in just five years, SRI is shaping the future of commercialized healthcare innovation. Whether through licensing, startup creation, or industry collaboration, Sunnybrook continues to bridge research with impact, transforming ideas into life-saving solutions.

Sunnybrook is at the forefront of the AI revolution in healthcare, transforming patient care through cutting-edge machine learning, medical imaging, and image-guided therapy (IGT). As a leader in AI-powered diagnostics, treatment planning, and precision medicine, Sunnybrook is harnessing artificial intelligence to improve accuracy, speed, and outcomes for patients. Through initiatives like INOVAIT, Canada’s national IGT and AI network, and its world-class research programs, SRI is driving next-generation innovations that are shaping the future of personalized, data-driven healthcare. 

Medventions, Sunnybrook’s flagship medtech innovation fellowship program, equips the next generation of scientists, engineers, and clinicians with the skills to develop, commercialize, and translate medical technologies. Through hands-on experience in healthcare entrepreneurship, product development, and regulatory pathways, Medventions fosters a pipeline of innovators ready to drive breakthroughs in image-guided therapy, AI, and medical device development.